(redirected from Esophageal cancer)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.


Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.


1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.


Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Mentioned in ?
References in periodicals archive ?
Shaheen, MD, MPH, is Chief of the Division of Gastroenterology and Hepatology at the University of North Carolina School of Medicine and is an internationally recognized clinician, educator and investigator and is an expert on Barrett's esophagus, reflux disease and esophageal cancer.
The WHO said esophageal cancer is the eighth most common cause of cancer worldwide and one of the main causes of cancer deaths, with 400,000, nearly five percent of all cancer deaths, recorded in 2012.
From this data, we can conclude that routine CT scans alone have a low diagnostic accuracy for staging of esophageal cancer and we should include another staging tool with CT scan to properly stage tumours and direct further treatment towards the right direction.
The patients were recruited in Department of Comprehensive Oncology, Chinese Academy of Medical Sciences Cancer Hospital (CAMSCH), including a total of 50 esophageal cancer in-patients, between June 2012 and April 2014.
The ascending incidence of esophageal cancer over the past two decades conformed to the change in histological type and primary tumor location.
Editor's note: The findings support the results of a clinical trial of supplementation with vitamin E and selenium which found a significant reduction in esophageal cancer deaths among younger participants, but not among older subjects who are likelier to have precancerous lesions.
GERD can lead to Barrett's esophagus, manifested by cellular changes in the lining of the lower part of the esophagus, which can increase the risk of esophageal cancer.
Food and Drug Administration recently reported 23 cases of esophageal cancer (between 1995 and 2008) in patients using the bisphosphohate alendronate and a further 31 cases in patients using bisphosphonates in Europe and Japan, possibly indicating risk of malignancy," they noted.
But researchers who examined the incidence of esophageal cancer in more than 80,000 people divided into two groups--those who took bisphosphonates and those who did not--found no significant difference between the incidence of esophageal cancer in the two groups.
Reflux esophagitis is a known risk factor for esophageal cancer, but it is not known whether bisphosphonate-associated esophagitis also predisposes patients to develop gastric cancer, said Chris R.

Full browser ?